Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Sezary Syndrome 4Mycosis Fungoides 3Lymphoma, T-Cell, Cutaneous 3Neoplasms 2Graft vs Host Disease 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Myelodysplastic Syndromes 1Lymphoma, Non-Hodgkin 1Leukemia, Myeloid 1Leukemia, Lymphoid 1Leukemia 1Immunologic Deficiency Syndromes 1Hodgkin Disease 1Hemoglobinopathies 1Hematologic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

fludarabine 4fludarabine phosphate 3Thiotepa 2Melphalan 2Clofarabine 2Busulfan 2Tacrolimus 1Photopheresis 1Mycophenolic Acid 1Methylprednisolone Hemisuccinate 1Methylprednisolone 1Cyclosporins 1Cyclophosphamide 1Clinical Trials, Phase I as Topic 1Bone Marrow Transplantation 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Hemoglobinopathies × Photopheresis × Clear all
NCT00179790 2017-03-06

Reduced Intensity Transplant Using Extracorporeal Photopheresis

Ann & Robert H Lurie Children's Hospital of Chicago

Phase 1/2 Completed
22 enrolled
Other hematologic neoplasm

Hemoglobinopathies, Immunologic Deficiency Syndromes, Leukemia, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡